Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: BJU Int. 2014 Aug 13;115(1):81–86. doi: 10.1111/bju.12769

Figure 1.

Figure 1

Decision curve of the final model predicting downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3+4 prostate cancer with the net benefit of assigning patients to active surveillance based on model (dashed line) compared to treating all patients with radical prostatectomy (solid black line) and treating all patients with active surveillance rather than radical prostatectomy (solid grey line).